Current trials of interventions to prevent radiocontrast-induced nephropathy

American Journal of Therapeutics

Volumn 12, Issue 2, 2005, Pages 127-132

  Asif, Arif ^a   Garces, Galo ^a   Preston, Richard A ^a   Roth, David ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Fenoldopam; Iso osmolar contrast medium; N acetylcysteine; Radiocontrast induced nephropathy; Renal replacement therapy

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CONTRAST MEDIUM; CREATININE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; FENOLDOPAM; IODIXANOL; IOHEXOL; PLACEBO;

ACUTE KIDNEY FAILURE; ANTIOXIDANT ACTIVITY; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYDRATION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; OSMOLARITY; PRIORITY JOURNAL; RADIOCONTRAST INDUCED NEPHROPATHY; REVIEW;

ACETYLCYSTEINE; ANTIOXIDANTS; CLINICAL TRIALS; CONTRAST MEDIA; DOPAMINE AGONISTS; FENOLDOPAM; HUMANS; ISOTONIC SOLUTIONS; KIDNEY FAILURE, ACUTE; OSMOLAR CONCENTRATION; RECEPTORS, DOPAMINE D1; SODIUM BICARBONATE; SODIUM CHLORIDE;

EID: 17144383267     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000143694.60662.11     Document Type: Review

References (31)

1. Levy EM, Viscoli CM, Horwitz RI. The effects of acute renal failure on mortality. JAMA. 1996;275:1489-1494.
2. Asif A, Preston RA, Roth D. Radiocontrast-induced nephropathy. Am J Ther. 2003;10:137-147.
3. Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349:1333-1340.
4. Singer I, Epstein M. In depth review: potential of dopamine A-1 agonist in the management of acute renal failure. Am J Kidney Dis. 1998;31:743-755.
5. Bakris GL, Lass NA, Clock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int. 1999;56:206-210.
6. Hunter DW, Chamsuddin A, Bjarnason H, et al. Preventing contrast-induced nephropathy with fenoldopam. Tech Vasc Interv Radiol. 2001;4:53-56.
7. Madyoon H, Croushore L, Weaver D, et al. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients. Catheter Cardiovasc Intern 2001;53:341-345.
8. Kini AA, Sharma SK. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention. Rev Cardiovasc Med. 2001;2(suppl 1):S19-S25.
9. Tumlin JA, Wang A, Murray PT, et al. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J. 2002;143:894-903.
10. Stone GW, McCullough PA, Tumlin JA, et al. CONTRAST Investigators: fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003;290:2284-2291.
11. Bakris GL, Lass N, Gaber O. Radiocontrast medium-induced decline in renal function: a role for oxygen free radicals. Am J Physiol 1990;258:F115-F120.
12. Baliga R, Ueda N, Walker PD, et al. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis. 1997;29:465-477.
13. DiMari J, Megyesi J, Udvarhelyi N, et al. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol. 1997;272: F292-F298.
14. Safirstein R, Andrade L, Vieira JM. Acetylcysteine and nephrotoxic effects of radiographic contrast agents-a new use for an old drug. N Engl J Med. 2000;343:210-212.
15. Tepel M, Van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180-184.
16. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (The APART Trial). Am J Cardiol. 2002;89:356-358.
17. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol. 2002;40:298-303.
18. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol. 2002,40:1383-1388.
19. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA. 2003;289:553-558.
20. Baker CS, Wragg A, Kumar S, et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol. 2003;41:2114-2118.
21. Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet. 2003;362:598-603.
22. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int. 1995;47:254-261.
23. Grynne BH, Nossen JO, Bolstad B, et al. Main results of the first comparative clinical studies on Visipaque. Acta Radiol Suppl. 1995;399:265-270.
24. Murakami R, Tajima H, Kumazaki T, et al. Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate. Acta Radiol. 1998;39:368-371.
25. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol. 1999;72:701-703.
26. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators: Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491-499.
27. Cigarroa RG, Lange RA, Williams RH, et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86:649-652.
28. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329-336.
29. Vogt B, Ferrari P, Schonholzer C, et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med. 2001;111:692-698.
30. Frank H, Werner D, Lorusso V, et al. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol. 2003;60:176-182.
31. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328-2334.